The Board

Ms Peach has more than 20 years of commercial experience in the pharmaceutical industry, particularly in marketing, commercialising products and technologies and business development in local and international markets, working for major industry players such as CSL Limited and Merck Sharp & Dohme, the Australian subsidiary of Merck Inc. Ms Peach’s most recent executive position was as the Managing Director for Australia and New Zealand and Executive Vice President, South Asia Pacific for Fresenius Kabi, a leading provider of pharmaceutical products and medical devices to hospitals. Previously, Ms Peach was Vice President, Business Development R&D; for CSL, a position she held for ten years. In addition to her role as a Non-Executive Director of BVT, Ms Peach is a Non-Executive Director of ASX-listed Vision Eye Institute Limited and Starpharma, and early stage medical technology company 4Dx. Ms Peach is a graduate member of the Australian Institute of Company Directors.